Fig. 2From: Uro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility studyStandard Protocol Items: Recommendations for Interventional Trials (SPIRIT) DiagramBack to article page